Vilin Bio Med faces an open offer by new acquirers for 26% stake at ₹23.40/share (₹8.49 Cr). This follows their 60.63% acquisition (₹17.17 Cr), leading to ~87.89% control post-offer. FY25 revenue was ₹14.81 Cr, PAT ₹0.22 Cr. The company was recently fined ₹33,040 for non-appointment of Company Secretary.